Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.

Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Abstract Text:

    t murakamiT Murakami,h nakamuraH Nakamura,k tsudaK Tsuda,k nakanishiK Nakanishi,s horiS Hori,k tomodaK Tomoda,t mitaniT Mitani,t kozukaT Kozuka,m mondenM Monden,k wakasaK Wakasa,

    OBJECTIVE. We evaluated the usefulness of an MR imaging technique that used dynamic three-dimensional Fourier transformation (3DFT) fast imaging with steady-state precession (FISP) with gadopentetate dimeglumine for detecting viable regions of hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil (Lipiodol). Images obtained with the 3DFT FISP technique were directly correlated with hepatectomy specimens. SUBJECTS AND METHODS. Dynamic 3DFT FISP MR imaging was performed after transcatheter arterial chemoembolization and before partial hepatectomy in 10 patients with 10 tumors of hepatocellular carcinoma. Imaging parameters were 20/8/30 degrees (TR/TE/flip angle) with a slab thickness of 21-75 mm and seven or 15 partitions. 3DFT FISP images were obtained at the slice level where a tumor had been detected on T1- and/or T2-weighted spin-echo MR images before, just after (early phase), and 1 and 2 min after (late phase) IV administration of gadopentetate dimeglumine (0.1 mmol/kg). We directly compared the dynamic MR images of the 10 patients with the gross and microscopic findings. RESULTS. On early-phase images, tumors of hepatocellular carcinoma showed no enhancement in three patients and partial intense enhancement in seven. Viable regions of the tumor showed intense enhancement relative to the surrounding liver parenchyma in the early phase, whereas necrotic regions showed no enhancement in either the early or the late phase. Both viable and necrotic regions had lower signal intensities than did the surrounding liver parenchyma in the late phase. By using dynamic 3DFT MR imaging, we were able to accurately assess the effect of transcatheter arterial chemoembolization with iodized oil in nine of the 10 patients. However, in one patient in whom microscopically viable cells were seen in the capsule of the carcinoma, viable regions could not be detected with our technique. CONCLUSION. Dynamic 3DFT MR imaging was useful in differentiating viable regions of hepatocellular carcinoma from necrotic regions following transcatheter arterial chemoembolization with iodized oil.

    Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Publishing Authors By Initials

    t murakamiT Murakami,h nakamuraH Nakamura,k tsudaK Tsuda,k nakanishiK Nakanishi,s horiS Hori,k tomodaK Tomoda,t mitaniT Mitani,t kozukaT Kozuka,m mondenM Monden,k wakasaK Wakasa,

    For similar organic chemicals: amines: polyamines: pentetic acid research abstracts see: organic chemicals: amines: polyamines: pentetic acid research

    PUBMED ID PMID:

    MEDLINE DATE:

    Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: AJR. American journal of roentgenology

    VOLUME: 160

    Page Numbers: 295-9

    Journal Abbreviation:

    ISSN: 0361-803X

    DAY: 15

    MONTH: Feb

    YEAR: 1993

    Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7708173

    Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Keywords Mesh Terms:

    KEYWORDS: Pentetic Acid

    MESH TERMS: diagnostic use

    Chemical & Substance for Abstract: Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. Information

    Substance Name: Gadolinium DTPA

    Registry Number: 80529-93-7

    Grant and Affiliation Information for Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.

    AFFILIATION: Department of Radiology, Osaka University Medical School, Japan.

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AJR Am J Roentgenol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News